The atopic dermatitis market is facing increased growth, with a projected market...
A study suggests that children may face a higher risk of harm if their father is...
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD...
NImmune Biopharma and BioTherapeutics have partnered to develop new precision me...
German life science company Evotec has announced a collaboration with X-Chem to ...
The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology pr...
Biogen plans to apply for regulatory approval of this investigational dose regim...
The company had focused its resources on Filspari’s launch in IgAN after the US ...
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-hom...
The UK government has taken a step towards banning xylazine and 21 other substan...
ArsenalBio has secured $325m in a Series C financing round to propel its program...
Eli Lilly and EVA Pharma have formed a partnership to increase the availability ...
A panel of researchers gave presentations on the clinical evidence for the role ...
The subanalyses recontextualised data from the PACMAN-AMI trial on the therapeut...
